These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 30455372)

  • 21. Stepwise engineering of heterodimeric single domain camelid VHH antibodies that passively protect mice from ricin toxin.
    Vance DJ; Tremblay JM; Mantis NJ; Shoemaker CB
    J Biol Chem; 2013 Dec; 288(51):36538-47. PubMed ID: 24202178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA immunization combined with scFv phage display identifies antagonistic GCGR specific antibodies and reveals new epitopes on the small extracellular loops.
    van der Woning B; De Boeck G; Blanchetot C; Bobkov V; Klarenbeek A; Saunders M; Waelbroeck M; Laeremans T; Steyaert J; Hultberg A; De Haard H
    MAbs; 2016; 8(6):1126-35. PubMed ID: 27211075
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of llama single-domain antibodies against methotrexate, a prototypical hapten.
    Alvarez-Rueda N; Behar G; Ferré V; Pugnière M; Roquet F; Gastinel L; Jacquot C; Aubry J; Baty D; Barbet J; Birklé S
    Mol Immunol; 2007 Mar; 44(7):1680-90. PubMed ID: 17011035
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative analysis of EGFR-targeting antibodies for gold nanoparticle CT imaging of lung cancer.
    Ashton JR; Gottlin EB; Patz EF; West JL; Badea CT
    PLoS One; 2018; 13(11):e0206950. PubMed ID: 30408128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Llama VHH antibody fragments against GFAP: better diffusion in fixed tissues than classical monoclonal antibodies.
    Perruchini C; Pecorari F; Bourgeois JP; Duyckaerts C; Rougeon F; Lafaye P
    Acta Neuropathol; 2009 Nov; 118(5):685-95. PubMed ID: 19597828
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isolation of novel EGFR-specific VHH domains.
    Gottlin EB; Xiangrong Guan ; Pegram C; Cannedy A; Campa MJ; Patz EF
    J Biomol Screen; 2009 Jan; 14(1):77-85. PubMed ID: 19171923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rational identification of an optimal antibody mixture for targeting the epidermal growth factor receptor.
    Koefoed K; Steinaa L; Søderberg JN; Kjær I; Jacobsen HJ; Meijer PJ; Haurum JS; Jensen A; Kragh M; Andersen PS; Pedersen MW
    MAbs; 2011; 3(6):584-95. PubMed ID: 22123060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Glycosylphosphatidylinositol-Anchored Variable Region of Llama Heavy Chain-Only Antibody JM4 Efficiently Blocks both Cell-Free and T Cell-T Cell Transmission of Human Immunodeficiency Virus Type 1.
    Liu L; Wang W; Matz J; Ye C; Bracq L; Delon J; Kimata JT; Chen Z; Benichou S; Zhou P
    J Virol; 2016 Dec; 90(23):10642-10659. PubMed ID: 27654286
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Camelid heavy chain only antibody fragment domain against β-site of amyloid precursor protein cleaving enzyme 1 inhibits β-secretase activity in vitro and in vivo.
    Dorresteijn B; Rotman M; Faber D; Schravesande R; Suidgeest E; van der Weerd L; van der Maarel SM; Verrips CT; El Khattabi M
    FEBS J; 2015 Sep; 282(18):3618-31. PubMed ID: 26147692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel anti-EGFR monoclonal antibody inhibiting tumor cell growth by recognizing different epitopes from cetuximab.
    Hong KW; Kim CG; Lee SH; Chang KH; Shin YW; Ryoo KH; Kim SH; Kim YS
    J Biotechnol; 2010 Jan; 145(1):84-91. PubMed ID: 19828124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Joining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesis.
    Comor L; Dolinska S; Bhide K; Pulzova L; Jiménez-Munguía I; Bencurova E; Flachbartova Z; Potocnakova L; Kanova E; Bhide M
    Microb Cell Fact; 2017 Jan; 16(1):13. PubMed ID: 28114943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peptide mimotopes recognized by antibodies cetuximab and matuzumab induce a functionally equivalent anti-EGFR immune response.
    Hartmann C; Müller N; Blaukat A; Koch J; Benhar I; Wels WS
    Oncogene; 2010 Aug; 29(32):4517-27. PubMed ID: 20514015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Llama single-domain antibodies directed against nonconventional epitopes of tumor-associated carcinoembryonic antigen absent from nonspecific cross-reacting antigen.
    Behar G; Chames P; Teulon I; Cornillon A; Alshoukr F; Roquet F; Pugnière M; Teillaud JL; Gruaz-Guyon A; Pèlegrin A; Baty D
    FEBS J; 2009 Jul; 276(14):3881-93. PubMed ID: 19531051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Camelid Single-Domain Antibodies for the Development of Potent Diagnosis Platforms.
    Brilhante-da-Silva N; de Oliveira Sousa RM; Arruda A; Dos Santos EL; Marinho ACM; Stabeli RG; Fernandes CFC; Pereira SDS
    Mol Diagn Ther; 2021 Jul; 25(4):439-456. PubMed ID: 34146333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of physical chemical properties of llama VHH antibody fragments and mouse monoclonal antibodies.
    van der Linden RH; Frenken LG; de Geus B; Harmsen MM; Ruuls RC; Stok W; de Ron L; Wilson S; Davis P; Verrips CT
    Biochim Biophys Acta; 1999 Apr; 1431(1):37-46. PubMed ID: 10209277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccination with cetuximab mimotopes and biological properties of induced anti-epidermal growth factor receptor antibodies.
    Riemer AB; Kurz H; Klinger M; Scheiner O; Zielinski CC; Jensen-Jarolim E
    J Natl Cancer Inst; 2005 Nov; 97(22):1663-70. PubMed ID: 16288119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of subcellular localization on the efficiency of EGFR-targeted VHH photosensitizer conjugates.
    van Lith SAM; van den Brand D; Wallbrecher R; Wübbeke L; van Duijnhoven SMJ; Mäkinen PI; Hoogstad-van Evert JS; Massuger L; Ylä-Herttuala S; Brock R; Leenders WPJ
    Eur J Pharm Biopharm; 2018 Mar; 124():63-72. PubMed ID: 29274374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Competitive selection from single domain antibody libraries allows isolation of high-affinity antihapten antibodies that are not favored in the llama immune response.
    Tabares-da Rosa S; Rossotti M; Carleiza C; Carrión F; Pritsch O; Ahn KC; Last JA; Hammock BD; González-Sapienza G
    Anal Chem; 2011 Sep; 83(18):7213-20. PubMed ID: 21827167
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel monoclonal antibody specific for the de2-7 epidermal growth factor receptor (EGFR) that also recognizes the EGFR expressed in cells containing amplification of the EGFR gene.
    Johns TG; Stockert E; Ritter G; Jungbluth AA; Huang HJ; Cavenee WK; Smyth FE; Hall CM; Watson N; Nice EC; Gullick WJ; Old LJ; Burgess AW; Scott AM
    Int J Cancer; 2002 Mar; 98(3):398-408. PubMed ID: 11920591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and characterization of anti-FcgammaRIII (CD16) llama single-domain antibodies that activate natural killer cells.
    Behar G; Sibéril S; Groulet A; Chames P; Pugnière M; Boix C; Sautès-Fridman C; Teillaud JL; Baty D
    Protein Eng Des Sel; 2008 Jan; 21(1):1-10. PubMed ID: 18073223
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.